课题基金 / 基金详情

项目摘要

项目成果

William J. Federspiel的其他基金

相似基金

相关文献

中文摘要
翻译
急性和慢性肺部疾病仍然是死亡和住院的最致命原因, 儿科人群。囊性纤维化(CF)、肺动脉高压和肺纤维化已被观察到 是儿科患者肺衰竭的最常见原因。机械通气(MV)和 体外膜肺氧合(ECMO)已被用于连接患病儿童进行移植。这些 手术由于其对活动性的非常限制性的性质,可能导致移植后结果不佳。这个项目 将为儿科患者开发一种紧凑的呼吸辅助设备,匹兹堡儿科流动肺 (P-PAL)取代ECMO作为急性和慢性肺衰竭儿童移植或康复的桥梁。的 P-PAL是一种可穿戴的、完全集成的血泵和气体交换模块, 分别在右心房和肺动脉中植入流入插管和流出插管/移植物。 P-PAL将设计用于70 ℃下的长期呼吸支持(药筒更换前1-3个月)。 正常代谢氧合需求的90%,同时泵送血液从1升/分钟到2.5升/分钟。 项目的目标是:1)修改P-PAL的设计和操作参数,以满足以下要求: 血液泵送、气体交换、预充体积和形状因子,2)沿着设计构建P-PAL原型 泵送性能、气体交换和 通过开发新型两性离子聚合物,改善P-PAL的血液相容性 涂层,我们已经开始为我们的成人可穿戴辅助肺开发,和4)执行急性 在健康羔羊中进行的长期研究,以证明 PAAL装置,并研究其与心肺系统的相互作用。
英文摘要
Acute and chronic lung diseases remain the most life threatening causes of death and hospitalization in the pediatric population. Cystic fibrosis (CF), pulmonary hypertension and pulmonary fibrosis have been observed to be the most frequent causes of lung failure in pediatric patients. Mechanical ventilation (MV) and extracorporeal membrane oxygenation (ECMO) have been used to bridge sick kids to transplant. These procedures can lead to poor post-transplant outcomes by their very restrictive nature on mobility. This project will develop a compact respiratory assist device for pediatric patients, the Pittsburgh Pediatric Ambulatory Lung (P-PAL) to replace ECMO as a bridge to transplant or recovery in kids with acute and chronic lung failure. The P-PAL is a wearable and fully integrated blood pump and gas exchange module that will be designed for implantation of inflow cannula and outflow cannula/grafts in the right atrium and pulmonary artery, respectively. The P-PAL will be designed for longer-term respiratory support (1-3 months before cartridge change-out) at 70- 90% of normal metabolic oxygenation requirements, while pumping blood from 1 to 2.5 Liters/min. The specific aims of project are 1) To modify the design and operational parameters of the P-PAL to meet requirements for blood pumping, gas exchange, priming volume, and form factor, 2) To build P-PAL prototypes along the design development pathway for bench characterization studies of pumping performance, gas exchange, and hemolysis, 3) To improve the hemocompatibility of the P-PAL by exploiting novel polymeric zwitterionic coatings that we have already begun to develop for our adult wearable assist lung, and 4) To perform acute and chronic studies in healthy lambs to demonstrate the in-vivo performance and hemocompatibility of the PAAL device and to study its interaction with the cardiopulmonary system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hemoadsorption Device for Selective Removal of Cell-Free Plasma Hemoglobin During Extracorporeal Therapies.
Percutaneous Respiratory Assist Catheter
Design of Extracorporeal Specific Antibody Filters
Design of Extracorporeal Specific Antibody Filters
海外基金